Connecticut et al v. Teva Pharmaceuticals USA, Inc.

3:19-cv-00710

February 01, 2024
State-Led Generic Drug Cases Removed From MDL

The Judicial Panel on Multidistrict Litigation has sent a trio of cases from state-level enforcers back to federal court in Connecticut, separating them from the sprawling MDL centralized in Pennsylvania over claims of price fixing in the generic drug industry.
June 24, 2019
Drugmakers' Emails, Calls Show Price-Fix Coverup, AGs Say

Unredacted emails and phone records show Teva Pharmaceuticals, Pfizer Inc. and 18 other major U.S. drug manufacturers conspiring in an industrywide price-fixing scheme to keep the cost of hundreds of generic drugs artificially high, according to a complaint unsealed Monday by the Maryland attorney general's office.
June 04, 2019
44 States' Generic-Drug Pricing Suit Rolled Into Pa. MDL

A lawsuit filed in Connecticut last month by 44 state attorneys general accusing drugmakers of a sprawling scheme to fix generic-drug prices was transferred Tuesday to the Pennsylvania federal court overseeing multidistrict litigation over pricing in the industry.
May 13, 2019
Teva A 'Consistent Participant' In Drug Price-Fixing, AGs Say

Teva Pharmaceuticals is at the center of a sprawling new lawsuit in Connecticut in which a coalition of 44 state attorneys general accuse the drugmaker and more than a dozen rivals of conspiring to keep generics prices artificially high.